Article
DPYD Genotyping Recommendations: A Joint Consensus Recommendation of the Association for Molecular Pathology, American College of Medical Genetics and Genomics, Clinical Pharmacogenetics Implementation Consortium, College of American Pathologists, Dutch Pharmacogenetics Working Group of the Royal Dutch Pharmacists Association, European Society for Pharmacogenomics and Personalized Therapy, Pharmacogenomics Knowledgebase, and Pharmacogene Variation Consortium.
The Journal of molecular diagnostics : JMD - 1 Oct 2024
Pratt Victoria M, Cavallari Larisa H, Fulmer Makenzie L, Gaedigk Andrea, Hachad Houda, Ji Yuan, Kalman Lisa V, Ly Reynold C, Moyer Ann M, Scott Stuart A, Turner Amy J, van Schaik Ron H N, Whirl-Carrillo Michelle, Weck Karen E
Abstract excerpt
The goals of the Association for Molecular Pathology Clinical Practice Committee's Pharmacogenomics (PGx) Working Group are to define the key attributes of pharmacogenetic alleles recommended for clinical testing and a minimum set of variants that should be included in clinical PGx genotyping assays. This document series provides recommendations for a minimum set of variant alleles (tier 1) and an extended list...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
